CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 158 filers reported holding CLOVIS ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $117,000 | -7.9% | 97,995 | +39.0% | 0.00% | – |
Q2 2022 | $127,000 | -83.1% | 70,518 | -81.0% | 0.00% | – |
Q1 2022 | $750,000 | -24.9% | 371,296 | +0.7% | 0.00% | – |
Q4 2021 | $999,000 | -40.6% | 368,661 | -2.3% | 0.00% | – |
Q3 2021 | $1,683,000 | -3.4% | 377,296 | +25.7% | 0.00% | – |
Q2 2021 | $1,742,000 | -27.3% | 300,273 | -12.0% | 0.00% | – |
Q1 2021 | $2,395,000 | +17.8% | 341,256 | -19.4% | 0.00% | – |
Q4 2020 | $2,033,000 | -5.7% | 423,537 | +14.6% | 0.00% | -100.0% |
Q3 2020 | $2,155,000 | -6.4% | 369,653 | +8.3% | 0.00% | 0.0% |
Q2 2020 | $2,303,000 | +27.9% | 341,321 | +20.5% | 0.00% | 0.0% |
Q1 2020 | $1,800,000 | -12.9% | 283,142 | +42.9% | 0.00% | 0.0% |
Q4 2019 | $2,066,000 | +163.9% | 198,196 | -0.5% | 0.00% | – |
Q3 2019 | $783,000 | -76.6% | 199,132 | -11.5% | 0.00% | -100.0% |
Q2 2019 | $3,346,000 | -47.0% | 225,013 | -11.5% | 0.00% | -50.0% |
Q1 2019 | $6,311,000 | +44.8% | 254,260 | +4.8% | 0.00% | +100.0% |
Q4 2018 | $4,359,000 | -35.6% | 242,702 | +5.3% | 0.00% | -50.0% |
Q3 2018 | $6,770,000 | -38.8% | 230,497 | -5.3% | 0.00% | -33.3% |
Q2 2018 | $11,069,000 | -17.9% | 243,461 | -4.7% | 0.00% | -25.0% |
Q1 2018 | $13,488,000 | -21.2% | 255,459 | +1.5% | 0.00% | -20.0% |
Q4 2017 | $17,122,000 | -24.5% | 251,802 | -8.5% | 0.01% | -16.7% |
Q3 2017 | $22,688,000 | -67.0% | 275,326 | -62.5% | 0.01% | -68.4% |
Q2 2017 | $68,709,000 | +340.8% | 733,846 | +199.7% | 0.02% | +375.0% |
Q1 2017 | $15,588,000 | +101.4% | 244,821 | +40.5% | 0.00% | +100.0% |
Q4 2016 | $7,741,000 | +23.4% | 174,282 | +0.1% | 0.00% | 0.0% |
Q3 2016 | $6,274,000 | +177.6% | 174,027 | +5.6% | 0.00% | +100.0% |
Q2 2016 | $2,260,000 | -22.8% | 164,735 | +8.1% | 0.00% | 0.0% |
Q1 2016 | $2,927,000 | -47.1% | 152,430 | -3.6% | 0.00% | -50.0% |
Q4 2015 | $5,536,000 | -67.6% | 158,156 | -15.0% | 0.00% | -60.0% |
Q3 2015 | $17,109,000 | +5.4% | 186,051 | +0.7% | 0.01% | +25.0% |
Q2 2015 | $16,236,000 | +36.1% | 184,747 | +14.9% | 0.00% | +33.3% |
Q1 2015 | $11,932,000 | +41.0% | 160,738 | +6.4% | 0.00% | +50.0% |
Q4 2014 | $8,464,000 | +35.1% | 151,135 | +9.4% | 0.00% | 0.0% |
Q3 2014 | $6,264,000 | -43.1% | 138,097 | -48.1% | 0.00% | +100.0% |
Q2 2014 | $11,012,000 | +34.7% | 265,892 | +125.4% | 0.00% | -50.0% |
Q1 2014 | $8,173,000 | +31.3% | 117,983 | +14.2% | 0.00% | 0.0% |
Q4 2013 | $6,226,000 | -36.6% | 103,303 | -36.1% | 0.00% | +100.0% |
Q3 2013 | $9,824,000 | +77.0% | 161,592 | +95.0% | 0.00% | -50.0% |
Q2 2013 | $5,551,000 | – | 82,864 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |